Content about Acneiform eruptions

February 3, 2014

Onset Dermatologics, which makes prescription products for improving skin health, has announced the nationwide availability of Tretin-X (tretinoin, USP) Cream 0.075% for the treatment of acne.

CUMBERLAND, R.I. — Onset Dermatologics, which makes prescription products for improving skin health, has announced the nationwide availability of Tretin-X (tretinoin, USP) Cream 0.075% for the treatment of acne.

December 19, 2013

E'Shee Clinical Esthetic on Thursday announced the launch of Alpha and Omega, a new gene-therapy eye cream designed to target wrinkles, dark circles, puffiness and sagging skin.

PHILADELPHIA -- E'Shee Clinical Esthetic on Thursday announced the launch of Alpha and Omega, a new gene-therapy eye cream product designed to target wrinkles, dark circles, puffiness and sagging skin.

September 30, 2013

Envy Medical has expanded its ClarityMD line with the new Clarifying Acne Treatment Pads made with a gentle, alcohol-free formula that soothes skin with aloe.

WESTLAKE VILLAGE, Calif. — Envy Medical has expanded its ClarityMD line with the new Clarifying Acne Treatment Pads made with a gentle, alcohol-free formula that soothes skin with aloe.

September 4, 2013

The term "red state" takes on a new meaning when one looks not at politics, but at the incidence of a widespread but poorly understood skin disorder that causes reddening of the face.

BARRINGTON, Ill. – The term "red state" takes on a new meaning when one looks not at politics, but at the incidence of a widespread but poorly understood skin disorder that causes reddening of the face.

August 28, 2013

The Food and Drug Administration has approved a drug made by Galderma Labs for treating a side effect of rosacea in adults, the company said.

FORT WORTH, Texas — The Food and Drug Administration has approved a drug made by Galderma Labs for treating a side effect of rosacea in adults, the company said.

Galderma announced the approval of Mirvaso (brimonidine) topical gel in the 0.33% strength for the topical treatment of facial erythema of rosacea. The drug is applied once per day to reduce redness and lasts up to 12 hours. The company expects the drug to become available in pharmacies next month.

July 30, 2013

A new website for young people with acne allows them to receive online dermatology consultations and receive prescriptions.

MONTEREY, Calif. — A new website for young people with acne allows them to receive online dermatology consultations and receive prescriptions.

YoDerm charges $59 for a three-step plan. Users upload photos of their affected areas and answer several medical questions, a process that typically takes less than 10 minutes. Within 48 hours, a dermatologist examines the photos and information and creates a personalized treatment plan. After that, a treatment plan is delivered and, if included, a prescription is sent electronically to the user's preferred local pharmacy.

July 2, 2013

Murad announced the debut of Pore Reform, a skin care regimen that includes a Blackhead & Pore Clearing Duo to unclog and seal pores, shielding the skin from blackhead-causing dirt and debris.

EL SEGUNDO, Calif. — Murad has announced the debut of Pore Reform, a skin care regimen that includes a Blackhead & Pore Clearing Duo to unclog and seal pores, shielding the skin from blackhead-causing dirt and debris.

Featuring Oxidation Reversal Complex, proprietary technology that helps reverse and prevent sebum oxidation, Blackhead & Pore Clearing Duo is clinically proven to reduce the formation of blackheads by an average of 58%, the company stated.

July 2, 2013

Sandoz, the generics division of Swiss drug maker Novartis, announced the launch of metronidazole 1% topical gel, calling it the first generic version of Galderma Labs' Metrogel.

PRINCETON, N.J. — Sandoz has launched a generic topical drug for rosacea, the drug maker said Tuesday.

Sandoz, the generics division of Swiss drug maker Novartis, announced the launch of metronidazole 1% topical gel, calling it the first generic version of Galderma Labs' Metrogel. The drug is indicated for treating inflammatory lesions of rosacea, estimated to affect about 16 million Americans.

Metrogel had sales of about $110 million during the 12-month period that ended in April, according to IMS Health.

November 26, 2012

Ranbaxy Labs has launched a new treatment for acne under a licensing agreement with a Canadian drug maker.

PRINCETON, N.J. — Ranbaxy Labs has launched a new treatment for acne under a licensing agreement with a Canadian drug maker.

Ranbaxy announced Monday the launch of Absorbica (isotretinoin) capsules for treating severe recalcitrant nodular acne in patients ages 12 years and older. The drug was launched under a license from Mississauga, Ontario-based Cipher Pharmaceuticals.

Normally, oral isotretinoin must be taken with a high-fat meal due to its chemical properties, but Absorbica is designed to be taken without food.

August 22, 2012

Acne is the most common skin disorder within the United States, impacting millions of Americans and paving the way for researchers to feverishly develop new therapies and revamp existing treatment options at retail.

Acne is the most common skin disorder within the United States, impacting millions of Americans and paving the way for researchers to feverishly develop new therapies and revamp existing treatment options at retail.

While acne usually begins in puberty, the reality is that it is not restricted to any age group. Even adults in their 20s, 30s, 40s and 50s can develop acne.

August 21, 2012

EL SEGUNDO, Calif. — Murad, whose skin care products are available at such retailers as Ulta Beauty and Sephora, has announced the addition of the new Pore & Line Minimizing Hydrator to its Anti-Aging Acne Line, which was created to simultaneously reduce acne and aging concerns.

July 30, 2012

Generic drug maker Watson Pharmaceuticals is challenging the patent protection on a drug for acne and a drug for bronchospasm, the company said Monday.

PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals is challenging the patent protection on a drug for acne and a drug for bronchospasm, the company said Monday.

May 30, 2012

The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said.

PRINCETON, N.J. — The Food and Drug Administration has approved a branded acne drug made by Ranbaxy Labs, the drug maker said.

Ranbaxy announced the FDA approval of Absorica (isotretinoin), a drug for treating severe recalcitrant nodular acne. The company expects to launch Absorica in the United States in fourth quarter 2012 under an agreement with Canada-based Cipher Pharmaceuticals.

May 16, 2012

CoverAid has announced that its CoverAid therapeutic concealers now are available exclusively in Ulta Beauty stores nationwide.

WASHINGTON — CoverAid has announced that its CoverAid therapeutic concealers now are available exclusively in Ulta Beauty stores nationwide.

Developed by board-certified medical professionals, CoverAid therapeutic concealers help to hide blemishes, promote prompt healing and alleviate the redness usually associated with acne, scars and cold sores. CoverAid is available in three shades suitable for all skin types.

April 12, 2012

After more than 1 million people voted in Walmart's "Get On The Shelf Competition," America has chosen its top 10 most innovative products it would like to see on Walmart's shelves.

NEW YORK — After more than 1 million people voted in Walmart's "Get On The Shelf Competition," America has chosen its top 10 most innovative products it would like to see on Walmart's shelves. One of the winners is Bios Clinical Acne System, the brainchild of certified plastic surgeon Dr. Andrew Mark Klapper, Bios Systems has announced.

It carves out an entirely new niche in skin care called ProbioCosmetics, Bios Systems stated. Bios Clinical Acne System helps prevent and treat adolescent and adult acne.

March 19, 2012

Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

GREENSBORO, N.C. — Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

Mederma advanced scar gel is a transparent topical gel that contains Cepalin, the same proprietary botanical extract derived from onions used in all Mederma scar products and stretch marks therapy.

January 25, 2012

Having flawless-looking skin is not only a result of high-performing facial makeup that delivers exceptional coverage; it also really starts with clear, healthy skin.

Having flawless-looking skin is not only a result of high-performing facial makeup that delivers exceptional coverage; it also really starts with clear, healthy skin. That’s why it comes as no surprise that sales of facial cleansers and acne treatments are still on the rise.

According to data from SymphonyIRI Group, sales of facial cleansers rose about 4%, as sales of acne treatments rose 3.4% at food, drug and mass (excluding Walmart) during the 12 weeks ended Nov. 27.

 

 

January 18, 2012

Galderma Labs has launched a newly designed pump dispenser for a drug used to treat rosacea, the drug maker said Tuesday.

FORT WORTH, Texas — Galderma Labs has launched a newly designed pump dispenser for a drug used to treat rosacea, the drug maker said Tuesday.

Galderma announced the availability of the dispenser for MetroGel (metronidazole) gel in the 1% strength. The drug is used to treat bumps and blemishes in patients with rosacea. The Food and Drug Administration approved the pump in October.

January 10, 2012

La Roche-Posay is launching in March its new Rosaliac AR Intense Localized Redness Intensive Care, which reduces visible redness and irritation, and is suitable for rosacea-prone skin.

NEW YORK — La Roche-Posay is launching in March its new Rosaliac AR Intense Localized Redness Intensive Care, which reduces visible redness and irritation, and is suitable for rosacea-prone skin.

December 6, 2011

The Mentholatum Co. has announced that an independent testing group has found its OXY Maximum face wash to be an effective acne treatment at a great value and has endorsed it as a “bargain buy.”

ORCHARD PARK, N.Y. — The Mentholatum Co. has announced that an independent testing group has found its OXY Maximum face wash to be an effective acne treatment at a great value and has endorsed it as a “bargain buy.”

November 4, 2011

Sales of acne-fighting products have been on the rise, which comes as little surprise as manufacturers continue to develop innovative formulas and consumers strive for flawless, blemish-free skin.


Sales of acne-fighting products have been on the rise, which comes as little surprise as manufacturers continue to develop innovative formulas and consumers strive for flawless, blemish-free skin.


According to SymphonyIRI Group, sales of acne treatments increased 2.5% during the 12 weeks ended Oct. 2 at food, drug and mass (excluding Walmart).


July 14, 2011

A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.

BERLIN — A new study conducted by Bayer HealthCare suggests that an investigational treatment for acne may be suitable for patients with dark complexions whose acne includes a condition that causes irregular discoloration of the skin known as postinflammatory hyperpigmentation, or PIH.

June 29, 2011

In an effort to help those suffering from acne, La Roche-Posay has introduced its new Effaclar K Daily Renovating Anti-Relapse Acne Treatment 1, a daily treatment to address the ongoing, recurring life cycle of acne.

NEW YORK — In an effort to help those suffering from acne, La Roche-Posay has introduced its new Effaclar K Daily Renovating Anti-Relapse Acne Treatment 1, a daily treatment to address the ongoing, recurring life cycle of acne.

For the first time in a La Roche-Posay product, retinyl linoleate (a vitamin A derivative), salicylic acid and La Roche-Posay's exclusive lipo-hydroxy acid (LHA) molecule are combined to help treat mild acne and prevent its reoccurrence in acne sufferers of all ages.

June 13, 2011

More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

WASHINGTON — More than 200 drugs are under development in the United States for treating skin diseases, according to the country’s largest pharmaceutical industry trade group.

The Pharmaceutical Research and Manufacturers of America said Monday that the country’s drug makers were developing 263 medicines for skin diseases that affect more than one-third of the U.S population. A study by the Lewin Group found that the annual total cost of skin diseases was $39.3 billion in 2005.

February 7, 2011

GlaxoSmithKline company Stiefel has made its popular acne wash formulations available for over-the-counter use.

RESEARCH TRIANGLE PARK, N.C. — GlaxoSmithKline company Stiefel has made its popular acne wash formulations available for over-the-counter use.

Stiefel will market two products that are indicated for the treatment of acne over the counter under the PanOxyl brand: PanOxyl acne creamy wash will be available in 4% BPO and 8% BPO.

A marketing campaign directed toward pharmacists and dermatologists will communicate details of the new PanOxyl 4% and 8% BPO acne creamy washes. The products will be available for shipment in May.